Diagnosis and Treatment Modalities of Symptomatic Polycystic Kidney Disease

Güler, Sanem; Çimen, Sertaç; Hurton, Scott; Molinari, Michele

doi:10.15586/codon.pkd.2015.ch4

Cited by 1 publication

(1 citation statement)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 For patients with ADPKD who reach ESRD, kidney transplant is the preferred type of renal replacement therapy. 3 We aim to evaluate the demographics, outcomes, and complications of renal transplant in patients with ADPKD compared with other nephropathies.…”

Section: Introductionmentioning

confidence: 99%

Untitled

Barbouch

Hajji²,

Hedri³

et al. 2017

Exp Clin Transplant

View full text Add to dashboard Cite

Objectives: Autosomal dominant polycystic kidney disease is a common cause of end-stage renal disease and a common indication for renal transplant. This study was undertaken to evaluate the demographics, outcomes, and complications of renal transplant in patients with autosomal dominant polycystic kidney disease compared with other nephropathies. Materials and Methods: In a retrospective case-control design, we reviewed the records of 7 patients with autosomal dominant polycystic kidney disease from a total of 701 renal transplant patients over a 30-year period (1986-2016). For each patient, a matched control was selected based on sex, age, year of transplant, and type of kidney donor. We excluded patients who underwent kidney transplant abroad and those with a follow-up period of less than 2 years. Results: The number of patients with autosomal dominant polycystic kidney disease requiring transplant at our center was estimated at 0.23 per year, and the condition represented 1.57% of initial nephropathy causes. The mean patient age at transplant was 50.8 ± 8.05 years. There were 5 male and 2 female patients in the case group, with a male-to-female ratio of 2.5. The source of the graft was predominantly a living related donor (5/7). Four patients had extrarenal manifestations, the most common of which were liver cysts (3 patients). Rejection occurred in a single study patient (14.2%) and in 4 control patients (57.1%; P = .51). Two patients did not develop any complications. Complications noted after transplant included infection (3/7 cases vs 2/7 controls; P = .67) and cerebrovascular accidents (2/7 cases vs 0/7 controls). Conclusions:Further studies with longer follow-up and greater numbers of patients are needed to compare more precisely the complications and results of transplant between patients with autosomal dominant polycystic kidney disease and other kidney transplant recipients.

show abstract

Section: Introductionmentioning

confidence: 99%